First Time Loading...

Alnylam Pharmaceuticals Inc
NASDAQ:ALNY

Watchlist Manager
Alnylam Pharmaceuticals Inc Logo
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Watchlist
Price: 150.24 USD 0.56% Market Closed
Updated: May 21, 2024

Alnylam Pharmaceuticals Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alnylam Pharmaceuticals Inc
Pre-Tax Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Pre-Tax Income
-$324.8m
CAGR 3-Years
28%
CAGR 5-Years
17%
CAGR 10-Years
1%
Abbvie Inc
NYSE:ABBV
Pre-Tax Income
$7.5B
CAGR 3-Years
22%
CAGR 5-Years
9%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Pre-Tax Income
$1.1B
CAGR 3-Years
-18%
CAGR 5-Years
-33%
CAGR 10-Years
-16%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$4.3B
CAGR 3-Years
-18%
CAGR 5-Years
-14%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Pre-Tax Income
$4.8B
CAGR 3-Years
13%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Pre-Tax Income
$4B
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
18%

See Also

What is Alnylam Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
-324.8m USD

Based on the financial report for Mar 31, 2024, Alnylam Pharmaceuticals Inc's Pre-Tax Income amounts to -324.8m USD.

What is Alnylam Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
1%

Over the last year, the Pre-Tax Income growth was 69%. The average annual Pre-Tax Income growth rates for Alnylam Pharmaceuticals Inc have been 28% over the past three years , 17% over the past five years , and 1% over the past ten years .